New immune therapy tested for Tough-to-Treat blood cancer in japan
NCT ID NCT04696809
Summary
This study is testing an immunotherapy drug called teclistamab in Japanese patients whose multiple myeloma has returned or stopped responding to standard treatments. The first part checks the drug's safety, and the second part measures how well it works to shrink the cancer. About 40 participants will receive the treatment to see if it can help control their disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Japanese Red Cross Medical Center
Shibuya City, 150-8935, Japan
-
Japanese Red Cross Osaka Hospital
Osaka, 543-8555, Japan
-
Kameda Medical Center
Chiba, 296-8602, Japan
-
Kobe City Medical Center General Hospital
Kobe, 650 0047, Japan
-
Kurume University Hospital
Kurume, 830-0011, Japan
-
Kyoto Kuramaguchi Medical Center
Kyoto, 603-8151, Japan
-
Nagoya City University Hospital
Nagoya, 467 8602, Japan
-
National Hospital Organization Hiroshima-Nishi Medical Center
Ōtake, 739-0696, Japan
-
National Hospital Organization Kumamoto Medical Center
Kumamoto, 860-0008, Japan
-
National Hospital Organization Matsumoto Medical Center
Matsumoto, 399-8701, Japan
-
National Hospital Organization Mito Medical Center
Higashiibaraki-gun, 311-3193, Japan
-
National Hospital Organization Okayama Medical Center
Okayama, 701-1192, Japan
-
Niigata Cancer Center Hospital
Niigata, 951-8566, Japan
-
Ogaki Municipal Hospital
Gifu, 503-8502, Japan
-
Osaka International Cancer Institute
Osaka, 541 8567, Japan
Conditions
Explore the condition pages connected to this study.